Search Results - "Giraldo‐Velasquez, Mario"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Oligodendrocyte‐specific deletion of FGFR2 ameliorates MOG35‐55‐induced EAE through ERK and Akt signalling by Kamali, Salar, Rajendran, Ranjithkumar, Stadelmann, Christine, Karnati, Srikanth, Rajendran, Vinothkumar, GiraldoVelasquez, Mario, Berghoff, Martin

    Published in Brain pathology (Zurich, Switzerland) (01-03-2021)
    “…Fibroblast growth factors (FGFs) and their receptors (FGFRs) are involved in demyelinating pathologies including multiple sclerosis (MS). In our recent study,…”
    Get full text
    Journal Article
  3. 3

    Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation by Rajendran, Ranjithkumar, GiraldoVelásquez, Mario, Stadelmann, Christine, Berghoff, Martin

    Published in Brain pathology (Zurich, Switzerland) (01-03-2018)
    “…Fibroblast growth factors (FGFs) exert diverse biological effects by binding and activation of specific fibroblast growth factor receptors (FGFRs). FGFs and…”
    Get full text
    Journal Article
  4. 4

    Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG 35-55 -induced EAE through ERK and Akt signalling by Kamali, Salar, Rajendran, Ranjithkumar, Stadelmann, Christine, Karnati, Srikanth, Rajendran, Vinothkumar, Giraldo-Velasquez, Mario, Berghoff, Martin

    Published in Brain pathology (Zurich, Switzerland) (01-03-2021)
    “…Fibroblast growth factors (FGFs) and their receptors (FGFRs) are involved in demyelinating pathologies including multiple sclerosis (MS). In our recent study,…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Toxoplasma gondii in Primary Rat CNS Cells: Differential Contribution of Neurons, Astrocytes, and Microglial Cells for the Intracerebral Development and Stage Differentiation by Lüder, Carsten G.K., Giraldo-Velásquez, Mario, Sendtner, Michael, Gross, Uwe

    Published in Experimental parasitology (01-09-1999)
    “…Lüder, C. G. K., Giraldo-Velásquez, M., Sendtner, M., Gross, U. 1999. Toxoplasma gondii in primary rat CNS cells: Differential contribution of neurons,…”
    Get full text
    Journal Article
  12. 12

    No association of the structural dopamine D2 receptor (DRD2) variant 311Cys with alcoholism by Finckh, U, von Widdern, O, Giraldo-Velasquez, M, Podschus, J, Dufeu, P, Sander, T, Harms, H, Schmidt, L G, Rommelspacher, H, Rolfs, A

    “…The human dopamine D2 receptor (DRD2) has been implied in the vulnerability for alcoholism and/or the modification of its severity. This is supported through…”
    Get more information
    Journal Article
  13. 13

    Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA by Lüder, Carsten G.K, Lang, Christine, Giraldo-Velasquez, Mario, Algner, Michaela, Gerdes, Jens, Gross, Uwe

    Published in Journal of neuroimmunology (2003)
    “…Major histocompatibility complex (MHC) class II expression by microglia and astrocytes is critical for CD4+-mediated immune responses within the central…”
    Get full text
    Journal Article
  14. 14

    Fgfr2 and Fgfr3 are not required for patterning and maintenance of the midbrain and anterior hindbrain by Blak, Alexandra A., Naserke, Thorsten, Saarimäki-Vire, Jonna, Peltopuro, Paula, Giraldo-Velasquez, Mario, Vogt Weisenhorn, Daniela M., Prakash, Nilima, Sendtner, Michael, Partanen, Juha, Wurst, Wolfgang

    Published in Developmental biology (01-03-2007)
    “…The mid-/hindbrain organizer (MHO) is characterized by the expression of a network of genes, which controls the patterning and development of the prospective…”
    Get full text
    Journal Article
  15. 15

    Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism by Finckh, U, Rommelspacher, H, Kuhn, S, Dufeu, P, Otto, G, Heinz, A, Dettling, M, Giraldo-Velasquez, M, Pelz, J, Gräf, K J, Harms, H, Sander, T, Schmidt, L G, Rolfs, A

    Published in Pharmacogenetics (London) (01-08-1997)
    “…The present study was performed to test the hypotheses that allelic variants at the human dopamine D2 receptor gene locus (DRD2) confer susceptibility to…”
    Get more information
    Journal Article
  16. 16

    Dopamine D2 receptor gene ( DRD2) haplotypes in Caucasians by Finckh, Ulrich, Giraldo-Velasquez, Mario, Pelz, Jörg, Otto, Gabriele, Sander, Thomas, Schmidt, Lutz G., Rommelspacher, Hans, Rolfs, Arndt

    Published in Gene (14-11-1996)
    “…The human dopamine D2 receptor gene ( DRD2) is considered a candidate gene for neuro-psychiatric diseases. We typed three new DNA sequence variants in DRD2…”
    Get full text
    Journal Article